Position
Squarepoint Ops LLC in Amicus Therapeutics Inc
Back to the book · All holders of AMICUS THERAPEUTICS INC
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $59.2K$14.24 → $14.46
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 269.3K | $3.83M | — | — | — | 0.0% |
| Q1 2026 | 1.71M | $24.7M | $14.46 | $59.2K | $20.8M | 0.0% |